Level of Acceptances

Cairn Energy PLC 10 October 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN 10 October 2007 Recommended offer for medOil plc declared unconditional in all respects On 7 September 2007, Capricorn Petroleum Limited (a subsidiary of Cairn Energy PLC) ('Capricorn') announced the terms of a recommended cash offer to be made by Jefferies on behalf of Capricorn for the entire issued and to be issued share capital of medOil plc ('medOil') at a price of 23 pence per medOil Share. The Offer Document containing details of the Offer was posted to medOil Shareholders on 18 September 2007. The Board of Capricorn is pleased to announce that all conditions of the Offer have now been satisfied or waived and that the Offer is declared unconditional in all respects. Total valid acceptances, together with medOil Shares otherwise acquired by Capricorn, represent in aggregate, approximately 93.0 per cent. of the existing share capital of medOil. The Offer remains open for acceptance until further notice. Level of Acceptances The Board of Capricorn announces that, as at 1.00 p.m. on 9 October 2007 (being the first closing date of the Offer), valid acceptances of the Offer had been received in respect of a total of 42,342,000 medOil Shares, which, together with a further 250,000 medOil Shares acquired by Capricorn since 18 September 2007, represent approximately 91.8 per cent. of the medOil Shares to which the Offer relates. The total of acceptances includes valid acceptances of the Offer received in respect of, in aggregate, 25,587,778 medOil Shares, representing approximately 47.2 per cent. of the existing issued share capital of medOil, and being all of the medOil Shares in respect of which irrevocable undertakings and letters of intent to accept the Offer had been received as at 7 September 2007. Share purchases and irrevocable undertakings to accept the Offer As at 17 September 2007 (being the latest practicable date prior to the posting of the Offer Document), Capricorn had acquired 7,869,000 medOil Shares, representing approximately 14.5 per cent of the existing issued share capital of medOil (taking into account an additional 200,000 shares issued since 17 September 2007). Capricorn subsequently acquired 250,000 medOil Shares, representing approximately 0.5 per cent. of the issued share capital of medOil. Accordingly, Capricorn has acquired, in aggregate, 8,119,000 medOil Shares, representing approximately 15.0 per cent. of the existing issued share capital of medOil. As at 17 September 2007 (being the latest practicable date prior to the posting of the Offer Document), Capricorn had received irrevocable undertakings from the medOil Directors that own medOil Shares and certain other medOil Shareholders to accept the Offer in respect of, in aggregate, 19,180,000 medOil Shares, representing approximately 35.4 per cent. of the existing issued share capital of medOil. In addition, as at 17 September 2007 (being the latest practicable date prior to the posting of the Offer Document), Capricorn had also received non-binding letters of intent from medOil Shareholders to accept the Offer in respect of, in aggregate, 6,407,778 medOil Shares, representing approximately 11.8 per cent. of the existing issued share capital of medOil. Save as disclosed herein, no medOil Shares have been acquired or agreed to be acquired by or on behalf of Capricorn or any person acting in concert with Capricorn during the Offer Period and neither Capricorn nor any person acting in concert with Capricorn has the benefit of any irrevocable commitment or letter of intent in respect of any medOil Shares or has any interest in any medOil Shares, or any short position (whether conditional or absolute and whether in the money or otherwise and including any short position under a derivative), any agreement to sell, any delivery obligation, any right to require another person to purchase or take delivery in respect of any medOil Shares, any right to subscribe for any medOil Shares or any stock borrowing or lending arrangement in respect of any medOil Shares. Settlement of consideration Settlement of cash consideration due under the Offer will be dispatched (or, in the case of medOil Shareholders holding medOil shares in uncertificated form, will be credited through CREST), within 14 days in respect of medOil Shares for which acceptances of the Offer, valid in all respects, have already been received. De-listing and compulsory acquisition of medOil Shares As Capricorn has received acceptances under the Offer in respect of 90 per cent. or more both of the nominal value of the medOil Shares to which the Offer relates and of the voting rights carried by such medOil Shares, Capricorn will as soon as practicable give notice to those medOil Shareholders who have not accepted the Offer informing them that it will compulsorily acquire their medOil Shares pursuant to its rights under the provisions of Sections 979 to 982 (inclusive) of the Companies Act 2006. Further to the Offer being declared unconditional in all respects, Capricorn will now procure that medOil applies, as soon as practicable, to the London Stock Exchange for the cancellation of the admission to trading of medOil shares on AIM. Delisting will significantly reduce the liquidity and marketability of any medOil Shares not acquired under the Offer at that time. Following the cancellation of the admission to trading of medOil's Shares on AIM, medOil may be re-registered as a private company in due course. Further acceptances medOil Shareholders who wish to accept the Offer, but have not yet done so, are strongly encouraged to complete and return a Form of Acceptance in accordance with the instructions set out in the Offer Document. If medOil Shares are held in CREST, acceptance should be made electronically so that the TTE instruction settles as soon as possible. Terms defined in the Offer Document dated 18 September 2007 have the same meaning in this announcement. ENQUIRIES For further information contact: Cairn Energy Mike Watts 0131 475 3000 Jann Brown Simon Thomson Jefferies Richard Kent 020 7618 3713 This announcement is not intended to and does not constitute, or form any part of, any offer to sell or any solicitation of any offer to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction. Any acceptance or other response to the Offer should be made only on the basis of the information contained or referred to in the Offer Document and (in the case of medOil Shares held in certificated form) the Form of Acceptance. The availability of the Offer to persons who are not resident in the United Kingdom may be affected by the laws of their relevant jurisdiction. Such persons should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdiction. Further details in relation to overseas shareholders will be contained in the Offer Document. Unless otherwise determined by Capricorn, and subject to any dispensation required from the Panel, the Offer is not being made, directly or indirectly, in or into or by the use of the mails of, or by any means or instrumentality (including, without limitation, telephonically or electronically) of interstate or foreign commerce of, or through any facilities of a national securities exchange of, the United States, Canada, Australia or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction. Accordingly, copies of this announcement are not being, and must not be mailed or otherwise forwarded, distributed or sent in, into or from the United States, Canada, Australia or Japan and all persons receiving this announcement (including nominees, trustees and custodians) must not mail or otherwise forward, distribute or send it in, into or from the United States, Canada, Australia or Japan. Doing so may render invalid any purported acceptance of the Offer. Notwithstanding the foregoing, Capricorn retains the right to permit the Offer to be accepted and any sale of securities pursuant to the Offer to be completed if, in its sole discretion, it is satisfied that the transaction in question can be undertaken in compliance with applicable law and regulation. Jefferies, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively as financial adviser to Cairn Energy and Capricorn and no one else in connection with the Offer and will not be responsible to anyone other than Cairn Energy and Capricorn for providing the protections afforded to clients of Jefferies or for providing advice in relation to the Offer. This information is provided by RNS The company news service from the London Stock Exchange
UK 100